Proteus
Proteos Expanding Facilities
Proteos has expanded its facility within the Southwest Michigan Innovation Center and became its first and only anchor tenant. Proteos now occupies... more >>
__________________________________
"Michigan 50 Companies to Watch"
>>Clark Smith, Governor Jennifer Granholm, & Bob Heinrikson identified above>>
Proteos, Inc. has been recognized as one of the "Michigan 50 Companies to Watch," an awards program sponsored by the Edward Lowe Foundation. Proteos received the... more >>
Welcome to Proteos
Proteos is a contract research organization (CRO) that provides high quality recombinant proteins and synthetic peptides to discovery researchers in the pharmaceutical industry and academia worldwide. At Proteos, Quality is our standard of performance; this applies both to our services and products and in customer communication and adherence to timelines. We have become a preferred provider for many large Pharma and biotech companies because our scientists provide the kind of high quality attention to detail that you want, both in the planning and execution of the work. Proteos scientists have been trained to be problem solvers; we are usually called upon not just to follow given protocols, but to develop new methodologies for producing proteins in quantities and at a purity consistent with customer specifications. Proteos holds all customer information and materials in strict confidence, whether it be in strategic consultation or during the performance of a contract.
Serving Our Clients
As a CRO, Proteos offers customers input ranging from consultation on strategies covering all aspects of protein expression and purification, to service and research in providing high quality proteins and peptides. We produce recombinant proteins in bacterial, yeast, insect, and mammalian cells, starting with cDNA, plasmids, or cell lines. For mammalian cells, we often develop clonal cell lines or stable transfection pools that enhance levels of production over transient transfection. Our staff is experienced in a vast repertoire of purification methods so that even untagged proteins can be brought to a state of purity consistent with requirements for structural analysis. Proteos applies a battery of analytical procedures to assure quality of its products, including protein sequencing and mass spectroscopy, and we can also aid in assay development, or in application of given protocols as part of quality assurance. Proteos produces larger peptides recombinantly. Our unique fusion partner enables the soluble expression of peptides in E. coli. As part of our protein product line, Proteos offers highly purified recombinant human renin and prorenin, with or without His-tags, and human β-secretase (BACE). Lastly, Proteos partners with pharmaceutical and biotech companies, as well as with universities and government agencies to explore new protein therapeutic products that will add to our intellectual property. Proteos Innovations is an LLC that Proteos has created to develop new ideas for commercialization in the protein field.